VYNE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology.
CEODavid Domzalski
CEODavid Domzalski
Employees13
Employees13
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2011
Founded2011
Employees13
Employees13
VYNE Key Statistics
Market cap18.99M
Market cap18.99M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume674.22K
Average volume674.22K
High today$0.5726
High today$0.5726
Low today$0.5564
Low today$0.5564
Open price$0.563
Open price$0.563
Volume125.88K
Volume125.88K
52 Week high$3.10
52 Week high$3.10
52 Week low$0.2805
52 Week low$0.2805
Stock Snapshot
The current VYNE Therapeutics(VYNE) stock price is $0.57, with a market capitalization of 18.99M. The stock trades at a price-to-earnings (P/E) ratio of -0.72.
During the trading session on 2026-01-14, VYNE Therapeutics(VYNE) shares reached a daily high of $0.57 and a low of $0.56. At a current price of $0.57, the stock is +1.5% higher than the low and still -1.3% under the high.
Trading volume for VYNE Therapeutics(VYNE) stock has reached 125.88K, versus its average volume of 674.22K.
Over the past 52 weeks, VYNE Therapeutics(VYNE) stock has traded between a high of $3.10 and a low of $0.28.
Over the past 52 weeks, VYNE Therapeutics(VYNE) stock has traded between a high of $3.10 and a low of $0.28.
People also own
Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.